News

Residential real estate developers are projected to see stable sales growth at 10-12 per cent this fiscal and the next, as d ...
Eli Lilly and Company (NYSE:LLY) is among the Goldman Sachs Stock Portfolio: 10 Large-Cap Stocks To Buy. On June 25, the ...
Mass. legislative leaders released a $61 billion budget deal that would outlaw mandatory tenant broker’s fees and rely more ...
Avery Dennison faces weakened fundamentals in 2025 despite prior cost-cutting and growth efforts. Read the latest analysis on ...
When investing pros say a stock looks cheap, discounted or overpriced, they’re often using a valuation metric, such as ...
In the second quarter of 2025, BMO reported net income of $1.9 billion, or $2.50 per share. Its dividend yield is around 4.4% ...
Canada's main stock index opened flat on Monday, as losses in energy shares countered gains in technology stocks, while ...
Marks & Spencer has delivered a multi-year turnaround with rising profits, margin expansion, and strong free cash flow, yet ...
Netease Cloud Music’s financial position has improved since the company began generating free cash flow in 2022. By the end of 2024, Cloud Music held a net cash position of nearly CNY 12 billion, ...
FDA issues a complete response letter for oxylanthanum carbonate, a treatment for hyperphosphatemia in patients with chronic ...
Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) edged up 2% after the company shared encouraging interim results ...
Investing.com -- Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) stock rose 2% following positive interim results from two Phase 2 clinical trials of its ARCT-810 mRNA therapeutic for ornithine ...